IBL HealthCare Limited

IBLHL

PK0095501018

Drug Retailers

End-of-day quote Pakistan S.E. Other stock markets 23:00:00 30/05/2024 BST			5-day change	1st Jan Change
32.66 ^PKR	-0.09%		-1.27%	-9.83%

04-29	IBL HealthCare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI
04-26	IBL Healthcare Limited Announces CEO Changes	CI

IBL HealthCare Ltd. Appoints A.M. Jalaluddin as Chief Executive Officer in Place of Rashid Abdulla

May 09, 2012

IBL HealthCare Ltd. announced that Mr. Rashid Abdulla chairman/chief executive/director has resigned from the office of the chief executive officer with effect from April 25, 2012 and Mr. A. M. Jalaluddin has been appointed as the chief executive officer the company in place of Mr. Rashid Abdulla.

Latest news about IBL HealthCare Limited

IBL HealthCare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	04-29	CI
IBL Healthcare Limited Announces CEO Changes	04-25	CI
IBL Healthcare Limited Announces Board Changes	04-25	CI
IBL HealthCare Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	02-29	CI
IBL HealthCare Limited Reports Earnings Results for the First Quarter Ended September 30, 2023	11-01	CI
IBL HealthCare Limited Reports Earnings Results for the Full Year Ended June 30, 2023	06/10/23	CI
IBL HealthCare Limited Reports Earnings Results for the Full Year Ended June 30, 2023	06/10/23	CI
IBL HealthCare Limited Announces Executive Changes	26/09/23	CI
IBL HealthCare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	02/05/23	CI
IBL HealthCare Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	01/03/23	CI
IBL HealthCare Limited Reports Earnings Results for the First Quarter Ended September 30, 2022	27/10/22	CI
IBL HealthCare Limited Reports Earnings Results for the Full Year Ended June 30, 2022	28/09/22	CI
IBL HealthCare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022	27/04/22	CI
IBL HealthCare Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021	28/02/22	CI
IBL HealthCare Limited Reports Earnings Results for the First Quarter Ended September 30, 2021	25/10/21	CI
IBL HealthCare Limited Reports Earnings Results for the Third Quarter Ended March 31, 2021	29/04/21	CI
Ibl Healthcare Limited Appoints Munis Abdullah and Mobeen Alam as Non-Executive Directors	01/03/21	CI
Ibl Healthcare Limited Reports Earnings Results for the Second Quarter Ended December 31, 2020	01/03/21	CI
IBL HealthCare Limited Proposes Final Cash Dividend for the Financial Year Ended June 30, 2020	02/10/20	CI
Ibl Healthcare Limited Reports Earnings Results for the Full Year Ended June 30, 2020	01/10/20	CI
IBL HealthCare Limited Appoints Mufti Zia Ul Islam as Chief Executive	18/06/20	CI
Ibl Healthcare Limited Reports Earnings Results for the Third Quarter Ended March 31, 2020	19/04/20	CI
Ibl Healthcare Limited Reports Earnings Results for the Second Quarter Ended December 31, 2019	27/02/20	CI
Ibl Healthcare Limited Reports Earnings Results for the Full Year Ended June 30, 2019	08/10/19	CI
Ibl Healthcare Limited Reports Earnings Results for the Third Quarter Ended March 31, 2019	15/04/19	CI

Chart IBL HealthCare Limited

Duration

Period

More charts

Company Profile

IBL HealthCare Limited is engaged in marketing, selling and distribution of healthcare products. The Company's product categories include nutrition, health, and wellness, ophthalmic, medical disposables, and pharmaceutical. The nutrition category includes toddlers, baby cereals, medical nutrition, lifestyle nutrition, specialty, and infant formulas. The health and wellness category includes consumer health, and hygiene and safety. The ophthalmic category includes vision care and pharma. The Medical Disposables category consists of renal care, critical care and anesthesia, non-drug, blood transfusion, IV administration, and medical gloves. The Pharmaceutical category consists of various products, such as Seapride, Luxave, Conifa, M-Floxin, Urisolin, Hyplar, Ezcolic, Clariza, and Eprazin. The Company is a subsidiary of The Searle Company Limited and International Brands Limited.

Sector

Drug Retailers

More about the company

Income Statement Evolution

More financial data

Sector Other Drug Retailers

	1st Jan change	Capi.
IBL HEALTHCARE LIMITED	-9.83%	10.05M
WALGREENS BOOTS ALLIANCE, INC.	-37.88%	13.99B
JD HEALTH INTERNATIONAL INC.	-32.23%	10.67B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-19.34%	6.75B
YIFENG PHARMACY CHAIN CO., LTD.	+12.54%	6.29B
MATSUKIYOCOCOKARA & CO.	-11.61%	5.88B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+75.00%	4.96B
NAHDI MEDICAL COMPANY	-2.92%	4.54B
CLICKS GROUP LIMITED	-9.20%	3.74B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	-19.40%	3.16B

Other Drug Retailers

IBL HealthCare Limited

Equities

IBLHL

PK0095501018

Drug Retailers

IBL HealthCare Ltd. Appoints A.M. Jalaluddin as Chief Executive Officer in Place of Rashid Abdulla

Latest news about IBL HealthCare Limited

Chart IBL HealthCare Limited

Company Profile

Income Statement Evolution

Sector Other Drug Retailers